ArticleFrontiers in oncology2021

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review.

Chao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.